- Home
- Research
- Funding Opportunities
- Siteman Investment Program Research Development Awards (SIP RDAs)
Siteman Investment Program Research Development Awards (SIP RDAs)
The SIP RDA 2026 Cycle 2 is now OPEN!
Required Statement of Intent Due Thursday, August 20th at 4pm CST.
Submit Required SOI Today!
RFA NOTE: Please click on the accordion menu below for the category you are interested in to access the category-specific RFA. There is no longer one main SIP RDA RFA, but instead individual RFAs for each funding category.
2026 Cycle 2 Official Dates
Announcement: July 23, 2026
Statement of Intent (REQUIRED) due via Microsoft Forms: August 20, 2026 at 4pm CST
Full Application Due: September 24, 2026 at 4PM CST
Anticipated decision notice: December 31, 2026
Start date: January 1, 2027
SIP RDA Categories
Synopsis: Supports discrete, specified hypothesis-driven research projects including secondary analyses, pilot studies, technology development, and other small self-contained research projects. Preliminary data is required.
Max Amount and Period: $200,000 over 2 years
Application Forms:
SIP RDA Application Cover Sheet Form – (required – updated 07/2026) – for all non-GIDA applications.
Questions? Contact Steve Baer at Siteman Cancer Center for more information at [email protected].
Synopsis: Supports projects focused on addressing prevention and control within the catchment area, including but not limited to: reducing the cancer burden, health policy, tobacco control, maximizing benefits of cancer genetics research, survivorship, and implementation and dissemination of evidence-based cancer control initiatives.
Max Amount and Period: $200,000 over 2 years
Application Forms:
SIP RDA Application Cover Sheet Form – (required – updated 07/2026) – for all non-GIDA applications.
Questions? Contact Steve Baer at Siteman Cancer Center for more information at [email protected].
Synopsis: Supports collaborative pre-R01 research projects between WashU and Univ. of Missouri faculty members. Each must be in the role of co-PI, dedicate 5% to project, and have comparable budgets.
Max Amount and Period: $200,000 over 2 years
Application Forms:
SIP RDA Application Cover Sheet Form – (required – updated 07/2026) – for all non-GIDA applications.
Questions? Contact Steve Baer at Siteman Cancer Center for more information at [email protected].
Synopsis: Supports discrete, hypothesis-driven translational science or clinically-focused research projects on head and neck cancer including mucosal cancers, salivary tumors, thyroid cancer, skin cancers, and other rare head and neck tumors.
Max Amount and Period: $200,000 over 2 years
Application Forms:
SIP RDA Application Cover Sheet Form – (required – updated 07/2026) – for all non-GIDA applications.
Questions? Contact Steve Baer at Siteman Cancer Center for more information at [email protected].
IMPORTANT: PI(s) and project leads are required to present all planned projects to SCC Senior Leadership prior to submitting SIP RDA Statement of Intent.
Synopsis: Supports well-established scientific teams with three or more projects, with an anticipated NCI/NIH submission timeline within 12-24 months of receipt of SIP RDA funds.
Max Amount and Period: $800,000 over 2 years
Application Forms:
SIP RDA Application Cover Sheet Form – (required – updated 02/2026) – for all non-GIDA applications.
Questions? Contact Steve Baer at Siteman Cancer Center for more information at [email protected].
Synopsis: Supports new (not yet active or active with zero accruals) institutional investigator-initiated, interventional trials unable to secure external funding.
Max Amount and Period: $300,000 over 3 years
Application Forms:
SIP RDA Application Cover Sheet Form – (required – updated 07/2026) – for all non-GIDA applications.
SIP RDA Clinical Trial Category Budget Form – (required – updated 02/2025)
Questions? Contact Steve Baer at Siteman Cancer Center for more information at [email protected].
formerly called Catchment Prevention and Control Trial Grants
Synopsis: Supports new or ongoing prevention and control-based interventional trials involving at least one health system partner (see list below) in SCC’s catchment area. Successful projects will accelerate dissemination and implementation research that moves evidence-based cancer practices into clinical and community settings and/or address the cancer burden in SCC’s catchment.
- SCC Satellites
- Barnes-Jewish West County Hospital
- Barnes-Jewish St. Peters Hospital
- Siteman Cancer Center South County
- Christian Hospital
- Memorial Hospital, Shiloh, IL
- SCC Network and BJC Collaborative Sites within Catchment
- BJC Alton Memorial Hospital, Alton, IL
- Phelps Health, Rolla, MO
- Southern Illinois Healthcare, Carbondale, IL
- Memorial Health of Springfield, IL
- Blessing Health System of Quincy, IL
- Sarah Bush Lincoln Health System of Mattoon, IL
Max Amount and Period: $100,000 over 2 years
Application Forms:
SIP RDA Application Cover Sheet Form – (required – updated 07/2026) – for all non-GIDA applications.
Questions? Contact Katie Hoey at Siteman Cancer Center for more information at [email protected].
Synopsis: Provides pilot funding to applicants who are interested in developing new research projects in the field of genome integrity in collaboration with current Center for Genome Integrity (CGI) members. The goal is to produce preliminary data to provide a basis for future NCI/NIH applications to be submitted in collaboration with a CGI faculty member.
Max Amount and Period: $100,000 over 2 years
Application Forms:
SIP RDA GIDA Application Cover Sheet Form – (required – updated 02/2025)
Questions? Contact Steve Baer at Siteman Cancer Center for more information at [email protected].
Synopsis: Provides supplemental funding to support community-engaged research to address the cancer burden within Siteman’s catchment area. All cancer-related research topics are eligible including basic science, clinical, population-based, and intervention research. Applicants may now apply for the COE supplement to parent grants for which they are not the PI, provided they submit a letter of support for the proposal from the parent grant PI.
Max Amount and Period: $50,000 for 1 year
Application Forms:
SIP RDA Application Cover Sheet Form – (required – updated 07/2026) – for all non-GIDA applications.
Questions? Contact Katie Hoey at Siteman Cancer Center for more information at [email protected].
Synopsis: The main goal of this award, provided by The William A. Martin Jr. and Hilda M. Martin Trust, is to support a WashU Medicine research project that is multidisciplinary and focuses on glioblastoma. The project should be innovative and involve at least two PIs from different departments.
Max Amount and Period: $50,000 for 1 year
Application Forms:
SIP RDA Application Cover Sheet Form – (required – updated 07/2026) – for all non-GIDA applications.
View Full Martin Glioblastoma Research Fund Award RFA
Questions? Contact Steve Baer at Siteman Cancer Center for more information at [email protected].
General SIP RDA Cycle Timelines
| GENERAL SIP DATE GUIDELINES* | Cycle 2 2026 Current Cycle | Cycle 1 2027 Next Cycle |
| Announcement: | July 23, 2026 | February 2027 |
| Statement of Intent deadline: REQUIRED Submit Today! | August 20, 2026 | March 2027 |
| Full Application Deadline: | Sept 24, 2026 | April 2027 |
| Anticipated decision notices: | Dec 31, 2026 | June 2027 |
| Start dates: | January 1, 2027 | July 1, 2027 |
| *Dates may vary based on weekends, holidays, and other unforeseen circumstances. Please consult the specific cycle’s RFA announcements for official deadlines. | ||
Success Rates
Success rates have been computed over the span of SIP RDA by mechanism and include applications that were scientifically reviewed. Success rates are determined by dividing the number of applications funded by the total number of applications reviewed. The current success rate for the Pre-R01 Category is 19%.
Re-submissions are welcome and encouraged every cycle. The success rate for re-submissions across all mechanisms is 29%.
Previous Awardees
For the full list of previous SIP RDA awardees, click HERE.
Contact
Contact Steve Baer at Siteman Cancer Center for more information or any questions.